Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK •...

33
Cross Sectional Imaging in Pancreatic Cancer Raneem Albazaz MBChB (Hons) BSc (Hons) MRCS FRCR Consultant GI Radiologist Leeds Teaching Hospitals NHS Trust

Transcript of Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK •...

Page 1: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

Cross Sectional Imaging in Pancreatic Cancer

Raneem Albazaz MBChB (Hons) BSc (Hons) MRCS FRCR

Consultant GI Radiologist

Leeds Teaching Hospitals NHS Trust

Page 2: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

Background

• 3% cancers in UK

• Ductal adenocarcinoma commonest

• Predilection for head and neck

• Obstructive jaundice

• Surgery primary treatment

• 5 year survival following resection only 10%

• NETs and cystic tumours less common but better prognosis

Vincent et al, Lancet 2011;378:607-620

Page 3: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

How is Suspected Pancreatic Cancer Investigated?

• Tumour markers

• Ultrasound

• Computed tomography (CT)

• Magnetic resonance imaging (MRI incl. MRCP)

• Endoscopic ultrasound (EUS)

• Endoscopic retrograde cholangiopancreatography (ERCP)

• Positron emission tomography (PET-CT)

• Other nuclear medicine eg. octreotide scan, nanocolloid

Page 4: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

How is Suspected Pancreatic Cancer Investigated?

• Tumour markers

• Ultrasound

• Computed tomography (CT)

• Magnetic resonance imaging (MRI incl. MRCP)

• Endoscopic ultrasound (EUS)

• Endoscopic retrograde cholangiopancreatography (ERCP)

• Positron emission tomography (PET-CT)

• Other nuclear medicine eg. octreotide scan, nanocolloid

Page 5: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

What is the Role of Imaging?

• Preoperative • Is it cancer?

• Localise tumour

• Is it resectable? • Local extent • Distant disease

• Anatomic variants • Vascular/biliary tree

• Post-operative • Identify complications • Recurrence

Page 6: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

What is the Role of Imaging?

• Palliative

• Size of tumour if chemorad considered (<5cm)

• Response to palliative treatment

Page 7: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

CT vs MRI

• If we know it’s cancer then it doesn’t matter which!

• Similar capability to assess local tumour extent

• NB. both can underestimate disease

Takakura et al. Abdom Imaging 2011;36:457-62

Motosugi et al, Radiology 2011;260:446-453

Verbeke et al, Pancreatology 2010;10:300

Page 8: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

Spatial Resolution (Clarity)

• CT better than MRI • Wide anatomical coverage • Comprehensive local and distant disease assessment • Rapid

• Eliminates artefact • Multi-planar reconstruction

Page 9: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive
Page 10: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

Contrast Resolution (Intensity)

• MRI better than CT • MRI parameters can be altered to improve resolution

• Better for lesion characterisation/detection

• Long examination time

Page 11: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

Liver lesion characterisation in pancreatic cancer ? Metastasis

Page 12: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

MRI

• Indications • Equivocal CT findings • Characterising lesions (primary tumour, liver lesion) • Defining anatomy of biliary tree and PD • Patient factors

• Renal impairment precluding CECT • Iodine contrast allergy

• Contraindications • Pacemaker • Aneurysm clips • Metal FB eye • Claustrophobia • Inability to breath hold

Page 13: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

56 year old male Abdominal pain, drinks half litre vodka per day

art

Page 14: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

56 year old male Drinks half litre vodka per day

T2 T1 T1 art

T1 delayed DWI ADC

Page 15: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

Staging CT

• Contrast

• Timing crucial

• Pancreas protocol

• Triple phase CAP

• Non contrast (calcification)

• Late arterial phase 35 sec (pancreatic phase = primary tumour & vessels)

• Portal venous phase 70 sec (metastases)

Page 16: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

86 year old female #NOF, acutely deranged LFTS

art pv non con

Page 17: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

Pancreatic Cancer Diagnosis

• Pancreatic adenocarcinoma • Hypovascular

• Compared to adjacent enhancing pancreas

• 10% isoattenuating • Secondary signs helpful • Double duct sign • Atrophic distal pancreas • Interrupted duct • Vascular occlusion

• Biliary stents / pancreatitis can be problematic

Page 18: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

62year old male Early satiety and epigastric pain, normal OGD, borderline abnormal LFTs

pv

pv

Page 19: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

54 year old female 6 week history central abdo pain radiating to back, dilated PD on US

non con

pv

art

MIP

Page 20: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

EUS

• Indeterminate findings on CT/MRI

• FNA possible

• Cytological assessment

• Operator dependent

• Limited availability

Page 21: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

Pancreatic Cancer Staging

• T staging (90% focal mass) • TX

• Primary tumor cannot be assessed • T0

• No evidence of primary tumor • Tis

• Carcinoma in situ • T1

• ≤ 2 cm in diameter and confined to the pancreas • T2

• > 2 cm in diameter and confined to the pancreas • T3

• Extension beyond pancreas but not involving coeliac axis or SMA • T4

• Involvement of coeliac axis, SMA, stomach, bowel (unresectable) • Lymphatic channels along coeliac axis or SMV

Page 22: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

Pancreatic Cancer Staging

• N staging • NX

• Regional lymph nodes not assessed

• N0 • No involvement of regional lymph nodes

• N1 • Involvement of regional lymph nodes

• Prognosis directly related to nodal involvement

• CT not accurate for nodal involvement

Roche et al, AJR 2003; 180:475–480

Geer et al, Am J Surg 1993; 165:68–73

Page 23: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

Pancreatic Cancer Staging

• CT limited in detection of small liver and peritoneal metastases

• Lung metastases not usually found if no other contraindication to surgery

Nordback et al, Scand J Gastroenterol 2004;39:81–86

Page 24: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

Vascular Resectability

• Venous invasion • PV • Splenic vein • SMV

• Gastrocolic trunk • First jejunal branch

• Arterial invasion • Coeliac trunk • Hepatic artery • SMA

Page 25: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

Vascular Invasion

• Loss of fat plane between tumour and vessel

• Flattening / slight irregularity of one side (ie. <180°) • Questionable involvement

• Tumour extending around at least two sides (ie. 180°) • Definite involvement, en bloc venous resection may still be

possible

• Circumferential narrowing or occlusion • Mostly unresectable • Short-segment focal venous occlusion may allow local resection

Page 26: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

72 year old male Abdo pain, hypotension, PR bleeding

pv

pv

pv

pv

Page 27: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

72 year old male Abdo pain, hypotension, PR bleeding

Page 28: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

72 year old male Abdo pain, hypotension, PR bleeding

T2 T1 + gad DWI ADC

Page 29: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

65 year old female Abdominal pain and distension, ascites on US

pv

pv

Page 30: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

58 year old female Upper abdo pain, dilated CBD on US

art

pv

Page 31: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

72 year old male Abdo and back pain with weight loss, normal OGD

art

art

pv

pv

Page 32: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

Follow-up

• No role for routine imaging post surgery

• Only if symptomatic

• Only if recurrence suspected clinically

• Assess response to chemotherapy in palliative cases

Page 33: Cross Sectional Imaging in Pancreatic Cancer · 2015-05-15 · Background • 3% cancers in UK • Ductal adenocarcinoma commonest • Predilection for head and neck • Obstructive

Take Home Points

• CT usually provides required information (pancreatic CT for staging)

• Other tests available for problem solving

• Consider suitability of test in clinical context